Position in ENOV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,939,956
+$4,176,042 QoQ
Shares Held
261,097
+294.3% QoQ
Ownership
0.454%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $1,200,961,606 across 58 Medical Devices names. ENOV ranks #19 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,611,020 | $226,591,504 | |
| 2 | SYK |
Stryker Corp
|
630,236 | $207,089,246 | |
| 3 | ABT |
Abbott Laboratories
|
2,010,938 | $206,463,003 | |
| 4 | EW |
Edwards Lifesciences Corp
|
1,996,377 | $159,869,868 | |
| 5 | PODD |
Insulet Corp
|
606,482 | $127,264,182 | |
| 6 | GMED |
Globus Medical Inc
|
562,630 | $48,476,200 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
1,442,472 | $27,652,186 | |
| 8 | HAE |
Haemonetics Corp
|
320,010 | $18,035,762 |
All Filings in ENOV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,939,956 | 261,097 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,763,914 | 66,213 | Shares | Other | 2026-02-13 | |
| 2024-12-31 | $6,210,468 | 141,533 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $576,226 | 9,227 | Shares | Other | 2024-05-15 | |
| 2023-06-30 | $8,010,832 | 124,935 | Shares | Other | 2023-08-14 | |
| 2022-09-30 | $670,364 | 14,551 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $975,205 | 17,731 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $4,569,008 | 114,828 | Shares | Other | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||